This reconciliation bill is being opposed by every Republican in Congress as well as the drug companies, the insurance companies, the fossil fuel industry and the billionaire class. They want to maintain the status quo in which the rich get richer.
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients.
Public Citizen, which called for the FDA acting commissioner "to immediately resign or be removed" over the "reckless and inexcusable" drug approval, welcomed her "belated" request.
Four companies have publicly raised concerns about how the Arkansas Department of Correction came to stockpile the drugs for its lethal injection cocktail — midazolam, vecuronium bromide and potassium chloride — but only the McKesson Corporation, the drug distributor that ranks fifth on the Fortune 500 list of companies, made an explicit allegation of deception.
Newly focused on an issue that is ravaging its members, the International Brotherhood of Teamsters on Thursday plans to challenge one of the world’s biggest pharmaceutical wholesalers, demanding that AmerisourceBergen Corp. investigate its own sales practices and potential supply chain diversions, and factor compliance into its executives’ pay.
“This is a drug that has long been a standard of care, and until recently it was widely accessible at an affordable price,” said Dr. Michael Kosnett, “There’s no justification for the astronomical price increases by Valeant, which limit availability to children with life-threatening lead poisoning.”
AARP, the non-profit seniors organization that exists to promote the financial security, pensions and healthcare of those over 50, is secretly funding the American Legislative Exchange Council (ALEC), an organization whose bills have acted against the interests of ordinary Americans, including retirees and their families. What can you do? -- sign the petition below.
Pfizer just raised drug prices for a second time this year—and it's not alone.
Pharmaceutical firms have a history of suppressing unfavourable results from drug trials. It’s time to compel them to publish data in full.
Many Americans do not to know that thalidomide was never approved for use in the US, and that was almost entirely due to the vigilance and, yes, outright stubbornness of one brave woman, who could sniff out spin and misinformation in a drug company application and would not be swayed by unrelenting pressure.
Spread the word